Antipsychotics (Unit 3 Loundsberry Lecture 5)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/43

encourage image

There's no tags or description

Looks like no tags are added yet.

44 Terms

1
New cards

Parkinson’s treatments

DA Replacement
LEVODOPA
Peripheral decarboxylase
inhibitor: CARBIDOPA

2
New cards

COMT inhibitor

entacapone

3
New cards

MAO B inhibitor

selegiline (Deprenyl)

4
New cards

DA receptor agonist

ROPINIROLE (Requip®)
Bromocriptine

5
New cards

Parkinson’s motor symptoms

progressive disease
 Tremor of rest
 Bradykinesia, Rigidity
 Postural defect: tendency to stoop
 Expressionless face
 Mortality: due to complications of severe
rigidity

6
New cards

Parkinson’s nonmotor symptoms

 Autonomic dysfunction (constipation)
 Sleep Disorder
 Dementia
 Depression
 Lack of Impulse Control, Psychosis

7
New cards

Pathophysiology of Parkinson’s

Progressive degeneration of neurons in the
Substantia Nigra (Pars Compacta): loss of DA
transmission
 clear model of disease using MPTP toxicity

  • DA/ACh balance


8
New cards

2 classes of dopamine receptors

  • D1 receptors (excitatory)

  • D2 receptors (inhibitory)


9
New cards

D1 and D2 Regulation of Basal
Ganglia output to the Thalamus

Direct pathway dominated by D1 receptors, Indirect Pathway dominated
by D2 receptors—both affect thalamic stimulation of the cortex

10
New cards

goal of therapy

Re-establish balance of
striatal signaling
 Increase DA signaling
 Decrease mACh signaling

11
New cards

Levodopa (L-DOPA)

 DA precursor
 crosses blood brain barrier
 actively taken up into neurons (aa
transporter)
 converted to DA by DA decarboxylase
 Bypasses the rate-limiting step (tyrosine
hydroxylase)

12
New cards

tyrosine hydroxylase

converts tyrosine —> DOPA

13
New cards

amino acid decarboxylase

converts DOPA —> dopamine

14
New cards

MAO

  • converts dopamine —> DOPAL

  • also converts norepinephrine —> DOPGAL


15
New cards

dopamine beta-hydroxylase

converts dopamine —> norepinephrine

16
New cards

adverse effects of LEVODOPA

dyskinesia
 hallucinations/confusion
 Drug interaction with classical
antipsychotics that inhibit DA receptors
 Can cautiously treat psychosis with
clozapine (no D2 effects)
 peripheral effects: nausea (DA
receptors in gut), hypotension
(unknown cause), arrhythmia

17
New cards

LEVODOPA dajunct therapy

  • treat w/ carbidopa (peripheral inhibitor of L-amino acid decarboxylase


  • prevents conversion to DA in periphery
     does not cross blood-brain barrier
     reduces peripheral side effects (i.e.
    nausea) and allows more drug to reach
    brain


18
New cards

Carbidopa effects on DA reaching
the brain

Increases the
fraction of drug that
reaches the brain
 Greatly reduces the
dose required

19
New cards

LEVODOPA adjunct therapy

  • use entacapone, which inhibits COMT (catechol-o-methyl transferase) in periphery

  • Prevents degradation of LEVODOPA

  • Adverse effects: dyskinesia, nausea and diarrhea


20
New cards

combination therapy

LEVODOPA
 Carbidopa
(DDC inhibitor)
 Entacapone

21
New cards

efficacy of LEVODOPA

Extremely effective early in
treatment
 over time development of motor
fluctuation
 possibly receptor adaptation
 effect reduced by increasing number of
dosages

22
New cards

selegiline

MAO B inhibitor

  • prevents metabolism of DA, NE, and 5-HT

  • reduces does of LEVODOPA needed


23
New cards

adverse effects of selegiline

Has some amphetamine-like side effects
(partly metabolized to amphetamine)
 metabolized in the liver by cytp450
enzymes

24
New cards

bromocriptine

other form of Parkinson’s treatment

25
New cards

ergot alkaloid

  • DA receptor agonist

  • treatment for Parkinson’s

  • activity at D1, D3, and 5-HT

  • Similar side effects to levodopa with more risk of
    psychotic effects
     Risk of cardiac valve fibrosis in long-term use


26
New cards

ropinirole

Less selective than Bromocriptine:
has D2, D3, D4 receptor agonist
activity
 Also useful treatment for Restless
Leg Syndrome

27
New cards

adverse effects of ropinirole

Metabolized by Cytp450 thus could
cause drug interactions
 Mostly has replaced Bromocriptine
therapeutically due to reduced side
effects

28
New cards

COMT

  • upregulated, used as add-on after L-DOPA therapy


29
New cards

classical D2 antagonists


HALOPERIDOL
• Treatment for Neuroleptic Malignant Syndrom
e: BROMOCRIPTINE

30
New cards

atypical antipsychotics

• RISPERIDONE
• CLOZAPINE
• QUETIAPINE
• ARIPIPRAZOLE (Abilify
™): Atypical D2/5HT partial agonist

31
New cards

dopamine hypothesis

  • all classical antipsychotics block D2 receptors

  • Parkinson’s patients treated w/ L-DOPA may have psychotic side effects


32
New cards

excess DA signaling

  • causes “positive symptoms” of schizophrenia


33
New cards

classical antiphychotics

  • D2 recpetor antagonists

  • mech: blocks excessive DA function in limbic system

  • replaced by Haloperidol (side effects)


34
New cards

haloperidol

  • sedation: early onset, tolerance

  • hypotension

  • extrayramidal effects:

  • tremor, akinesia, akathisia, tardive dyskinesia (late onset, can be irreversible)

  • neuroleptic malignant syndrome (autonomic deregulation)


35
New cards

neuroleptic malignant syndrome

  • runs in families

  • hyperpyrexia

  • autonomic instability

  • confusion

  • higher creatine kinase levels


36
New cards

neuroleptic malignant syndrome treatment

  • often in ICU

  • aggressive IV hydration and diuresis w/ bromocriptine


37
New cards

motor vs metabolic side effects

  • it’s a trade-off

  • Second-generation antipsychotics have improved effectiveness for
    emotional withdrawal and fewer motor effects
    • second-generation agents can produce adverse metabolic
    changes
    • Weight gain
    • Hyperlipidemia
    • Diabetes


38
New cards

2nd gen atypical antipsychotics (clozapine)

  • blocks D4=5-HT2=alpha=mACh=H

  • low potency

  • used for patients who develop dyscrinesia or Parkinson’s

  • most effective


39
New cards

2nd gen atypical antipsychotics (risperidone)

  • blocks D2=5-HT2 (better for negative symptoms)


40
New cards

2nd gen atypical antipsychotics (quetiapine/seroquel)

  • antagonist to D1, D2, 5-HT1A, and 5-HT2

  • similar to risperidone

  • side effects: very sedating

  • choice for people w/ sleep disorders


41
New cards

2nd gen atypical antipsychotics (aripiprazole)

  • newest antipsychotics

  • D2 and 5-HT1 partial agonist/antagonist (good b/c they don’t make symptoms severe)

  • #1 drug in sales, heavily marketed for depression


42
New cards

adverse effects of aripiprazole

  • less weight gain

  • metabolized by cytP450, so it can have drug interactions


43
New cards

summary of antipsychotics

  • all are effective in mania

  • clozapine most effective overall

  • aripiprazole also effective in depression


44
New cards

other uses for antipsychotics

  • Tourette’s

  • Huntington’s (progressive DA degeneration)

  • Haloperidol is drug of choice